Pharyngeal Carcinoma

Loading cancer entity…

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Public genomic cohorts	World · both sexes · all ages · latest · all malignant entities	#228 / 296	=	1 count	23.1	Medium confidence	ci-cohorts-v1	Sep 30, 2026	show formula: COUNT(genomic_cohorts) WHERE cancer_id IN descendants(cancer) counter cohortCount computedAt 2026-09-30T06:00:02.308Z inputs hash 401b2e31f9813fbae9c90ab7 Trace lineage (admin)
Publications, last 12 months	World · both sexes · all ages · latest · all malignant entities	#443 / 2,294	=	52 count	80.7	Medium confidence	ci-pubs-12m-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 12m counter publicationCount12m computedAt 2026-09-30T06:00:02.308Z inputs hash b1963bee32e72b8b6e51efec Trace lineage (admin)
Publications, last 5 years	World · both sexes · all ages · latest · all malignant entities	#430 / 2,873	=	296 count	85.1	Medium confidence	ci-pubs-5y-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 5y (query stored per row) counter publicationCount5y computedAt 2026-09-30T06:00:02.308Z inputs hash 7b01855837dd178dff17a0c3 Trace lineage (admin)
Trial registration growth (year over year)	World · both sexes · all ages · latest · all malignant entities	#101 / 186	=	0.07 ratio	45.9	Medium confidence	ci-trial-growth-v1	Sep 30, 2026	show formula: (new_trials_12m − new_trials_prior_12m) / new_trials_prior_12m (first_posted_date windows; interventional; descendants) asOf 2026-09-30 windows new12m to 2026-09-30 from 2025-09-30 prior12m to 2025-09-30 from 2024-09-30 studyType INTERVENTIONAL aggregation descendants
Active clinical trials	World · both sexes · all ages · latest · all malignant entities	#107 / 1,654	=	357 count	93.6	Medium confidence	ci-active-trials-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING) counter activeTrialCount computedAt 2026-09-30T06:00:02.308Z inputs hash d8f333d5bfdbadb41c05f9e2 Trace lineage (admin)
Active Phase III trials	World · both sexes · all ages · latest · all malignant entities	#45 / 810	=	106 count	94.6	Medium confidence	ci-phase3-trials-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) … active statuses AND PHASE3 = ANY(phases) counter phase3TrialCount computedAt 2026-09-30T06:00:02.308Z inputs hash 55bad1a93f2cbb5682249863 Trace lineage (admin)
Recruiting clinical trials	World · both sexes · all ages · latest · all malignant entities	#110 / 1,284	=	191 count	91.5	Medium confidence	ci-recruiting-trials-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL counter recruitingTrialCount computedAt 2026-09-30T06:00:02.308Z inputs hash 00002505dcded3e0217a182d Trace lineage (admin)
Recruiting Phase III trials	World · both sexes · all ages · latest · all malignant entities	#42 / 585	=	58 count	93	High confidence	ci-phase3-recruiting-v1	Sep 30, 2026	show formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND PHASE3 = ANY(phases) AND study_type = INTERVENTIONAL asOf 2026-09-30 studyType INTERVENTIONAL aggregation descendants activeTrials 357 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 phase3Recruiting 58 inputs hash 3f7191c10405ddd12eec0cad Trace lineage (admin)
Sponsor concentration (HHI)	World · both sexes · all ages · latest · all malignant entities	#246 / 614	=	0.075 index (0–1)	60	High confidence	ci-sponsor-hhi-v1	Sep 30, 2026	show formula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants asOf 2026-09-30 studyType INTERVENTIONAL topSponsor Sun Yat-sen University aggregation descendants activeTrials 357 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.25490198
Trial termination share	World · both sexes · all ages · latest · all malignant entities	#312 / 454	=	0.32 ratio	31.3	High confidence	ci-trial-termination-v1	Sep 30, 2026	show formula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL asOf 2026-09-30 since 2010-01-01 terminal 224 completed 153 studyType INTERVENTIONAL withdrawn 20 terminated 51 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING

Metric

Scope

Rank / eligible

Value

Percentile

Confidence

Formula

Generated

Inputs

Public genomic cohorts

World · both sexes · all ages · latest · all malignant entities

#228 / 296

1 count

23.1

Medium confidence

ci-cohorts-v1

Sep 30, 2026

show

formula: COUNT(genomic_cohorts) WHERE cancer_id IN descendants(cancer)

counter: cohortCount
computedAt: 2026-09-30T06:00:02.308Z

inputs hash 401b2e31f9813fbae9c90ab7

Trace lineage (admin)

Publications, last 12 months

World · both sexes · all ages · latest · all malignant entities

#443 / 2,294

52 count

80.7

Medium confidence

ci-pubs-12m-v1

Sep 30, 2026

show

formula: literature_counts.count WHERE window_key = 12m

counter: publicationCount12m
computedAt: 2026-09-30T06:00:02.308Z

inputs hash b1963bee32e72b8b6e51efec

Trace lineage (admin)

Publications, last 5 years

World · both sexes · all ages · latest · all malignant entities

#430 / 2,873

296 count

85.1

Medium confidence

ci-pubs-5y-v1

Sep 30, 2026

show

formula: literature_counts.count WHERE window_key = 5y (query stored per row)

counter: publicationCount5y
computedAt: 2026-09-30T06:00:02.308Z

inputs hash 7b01855837dd178dff17a0c3

Trace lineage (admin)

Trial registration growth (year over year)

World · both sexes · all ages · latest · all malignant entities

#101 / 186

0.07 ratio

45.9

Medium confidence

ci-trial-growth-v1

Sep 30, 2026

show

formula: (new_trials_12m − new_trials_prior_12m) / new_trials_prior_12m (first_posted_date windows; interventional; descendants)

asOf

2026-09-30

windows

new12m

to: 2026-09-30
from: 2025-09-30

prior12m

to: 2025-09-30
from: 2024-09-30

studyType

INTERVENTIONAL

aggregation

descendants

Active clinical trials

World · both sexes · all ages · latest · all malignant entities

#107 / 1,654

357 count

93.6

Medium confidence

ci-active-trials-v1

Sep 30, 2026

show

formula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)

counter: activeTrialCount
computedAt: 2026-09-30T06:00:02.308Z

inputs hash d8f333d5bfdbadb41c05f9e2

Trace lineage (admin)

Active Phase III trials

World · both sexes · all ages · latest · all malignant entities

#45 / 810

106 count

94.6

Medium confidence

ci-phase3-trials-v1

Sep 30, 2026

show

formula: COUNT(DISTINCT trial) … active statuses AND PHASE3 = ANY(phases)

counter: phase3TrialCount
computedAt: 2026-09-30T06:00:02.308Z

inputs hash 55bad1a93f2cbb5682249863

Trace lineage (admin)

Recruiting clinical trials

World · both sexes · all ages · latest · all malignant entities

#110 / 1,284

191 count

91.5

Medium confidence

ci-recruiting-trials-v1

Sep 30, 2026

show

formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL

counter: recruitingTrialCount
computedAt: 2026-09-30T06:00:02.308Z

inputs hash 00002505dcded3e0217a182d

Trace lineage (admin)

Recruiting Phase III trials

World · both sexes · all ages · latest · all malignant entities

#42 / 585

58 count

High confidence

ci-phase3-recruiting-v1

Sep 30, 2026

show

formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND PHASE3 = ANY(phases) AND study_type = INTERVENTIONAL

asOf: 2026-09-30
studyType: INTERVENTIONAL
aggregation: descendants
activeTrials: 357
activeStatuses: RECRUITING
NOT_YET_RECRUITING
ENROLLING_BY_INVITATION
ACTIVE_NOT_RECRUITING
formulaVersion: ci-trial-intel-v1
phase3Recruiting: 58

inputs hash 3f7191c10405ddd12eec0cad

Trace lineage (admin)

Sponsor concentration (HHI)

World · both sexes · all ages · latest · all malignant entities

#246 / 614

0.075 index (0–1)

High confidence

ci-sponsor-hhi-v1

Sep 30, 2026

show

formula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants

asOf: 2026-09-30
studyType: INTERVENTIONAL
topSponsor: Sun Yat-sen University
aggregation: descendants
activeTrials: 357
activeStatuses: RECRUITING
NOT_YET_RECRUITING
ENROLLING_BY_INVITATION
ACTIVE_NOT_RECRUITING
formulaVersion: ci-trial-intel-v1
minActiveTrials: 10
topSponsorShare: 0.25490198

Trial termination share

World · both sexes · all ages · latest · all malignant entities

#312 / 454

0.32 ratio

31.3

High confidence

ci-trial-termination-v1

Sep 30, 2026

show

formula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL

asOf: 2026-09-30
since: 2010-01-01
terminal: 224
completed: 153
studyType: INTERVENTIONAL
withdrawn: 20
terminated: 51
aggregation: descendants
activeStatuses: RECRUITING
NOT_YET_RECRUITING
ENROLLING_BY_INVITATION
ACTIVE_NOT_RECRUITING

Why this rank?

Research gap